Radmilo, M.; Pavelin, S.; Vujović, I.; Šoda, J.; Rogić Vidaković, M.
Confirmation of CD19+ B-Lymphocyte Depletion Prior to Intake of the Second Dose of Ocrelizumab in Multiple Sclerosis Patients. Biomedicines 2023, 11, 353.
https://doi.org/10.3390/biomedicines11020353
AMA Style
Radmilo M, Pavelin S, Vujović I, Šoda J, Rogić Vidaković M.
Confirmation of CD19+ B-Lymphocyte Depletion Prior to Intake of the Second Dose of Ocrelizumab in Multiple Sclerosis Patients. Biomedicines. 2023; 11(2):353.
https://doi.org/10.3390/biomedicines11020353
Chicago/Turabian Style
Radmilo, Marija, Sanda Pavelin, Igor Vujović, Joško Šoda, and Maja Rogić Vidaković.
2023. "Confirmation of CD19+ B-Lymphocyte Depletion Prior to Intake of the Second Dose of Ocrelizumab in Multiple Sclerosis Patients" Biomedicines 11, no. 2: 353.
https://doi.org/10.3390/biomedicines11020353
APA Style
Radmilo, M., Pavelin, S., Vujović, I., Šoda, J., & Rogić Vidaković, M.
(2023). Confirmation of CD19+ B-Lymphocyte Depletion Prior to Intake of the Second Dose of Ocrelizumab in Multiple Sclerosis Patients. Biomedicines, 11(2), 353.
https://doi.org/10.3390/biomedicines11020353